Publicaciones en las que colabora con José Ángel Berciano (12)

2017

  1. Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-Associated Parkinson disease

    Neurology, Vol. 89, Núm. 5, pp. 439-444

2016

  1. Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease

    Neurobiology of Aging, Vol. 38, pp. 214.e1-214.e5

2015

  1. Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls

    Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1105-1109

2014

  1. Serum uric acid and risk of dementia in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 20, Núm. 6, pp. 637-639

2013

  1. Genetic variability related to serum uric acid concentration and risk of Parkinson's disease

    Movement Disorders, Vol. 28, Núm. 12, pp. 1737-1740

  2. Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated parkinson disease

    Neurology, Vol. 80, Núm. 7, pp. 621-626

  3. Substantia nigra echogenicity in friedreich's ataxia patients

    Cerebellum, Vol. 12, Núm. 4, pp. 437-440

2011

  1. Aspectos controvertidos en el manejo de gliomas hemisféricos OMS grado II: Revisión de la bibliografía reciente

    Revista de Neurologia, Vol. 53, Núm. 12, pp. 747-757

  2. Genetic variation in α-synuclein kinases (CK-2β and GRK-5) and risk of Parkinson's disease

    Parkinsonism and Related Disorders

  3. High frequency and reduced penetrance of lRRK2 g2019S mutation among Parkinson's disease patients in Cantabria (Spain)

    Movement Disorders, Vol. 26, Núm. 13, pp. 2343-2346

  4. Interaction between heme oxygenase-1 genotypes and exposure to pesticides in Parkinson's disease

    Movement Disorders

2010

  1. Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3β) on the risk of Parkinson's disease

    European Journal of Neurology, Vol. 17, Núm. 5, pp. 760-762